C12Y 302/01084
Glucan 1,3-alpha-glucosidase , i.e. mutanase
Official title: Glucan 1,3-alpha-glucosidase (3.2.1.84), i.e. mutanase
C12Y302/01084 (Glucan 1,3-alpha-glucosidase , i.e. mutanase) appears on 24 US grants and 20 published applications in this corpus.
Search patents in C12Y- Granted patents
- 24
- Published applications
- 20
- Assignees
- 20
- Inventors
- 65
- Latest grant
- 17 May 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 3 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 2 |
| 2012 | 0 | 1 |
| 2013 | 1 | 3 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 2 | 3 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 3 | 0 |
| 2023 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Codon optimization for increasing transgene expression in chloroplasts of higher seed plants17 May 2022US 11,332,754 B2The Trustees of the University of Pennsylvania
- Compositions and methods for inhibiting biofilm deposition and production15 Feb 2022US 11,246,819 B2The Trustees of the University of Pennsylvania
- Yeast strains producing mammalian-like complex n-glycans18 Jan 2022US 11,225,646 B2Oxyrane UK Limited
- Genes encoding alpha-1,3-glucanase and methods of using the same12 Nov 2019US 10,472,616 B2Genofocus Co., Ltd.
- Yeast strains producing mammalian-like complex N-glycans14 May 2019US 10,287,557 B2Oxyrane UK Limited
- Compositions and methods for inhibiting biofilm deposition and production3 Aug 2023US 2023/0241186 A1
- Compositions and methods for inhibiting biolfilm deposition and production31 Oct 2019US 2019/0328643 A1The Trustees of the University of Pennsylvania
- Yeast strains producing mammalian-like complex n-glycans1 Aug 2019US 2019/0233802 A1Oxyrane UK Limited
- Codon optimization and ribosome profiling for increasing transgene expression in chloroplasts of higher plants27 Jun 2019US 2019/0194679 A1The Trustees of the University of Pennsylvania
- Novel alpha-1,3-glucanase19 Jul 2018US 2018/0201914 A1Genofocus Co., Ltd.
Most cited
By later US patents
- Mutanase-containing oral compositions30US 5,741,487 ALion Corporation · 1998
- Bacteria and enzymes for production of alternan fragments22US 5,786,196 AThe United States of America as represented by the Secretary of Agriculture · 1998
- Yarrowia lipolytica and Pichia pastoris HAC1 nucleic acids20US 8,026,083 B2Oxyrane UK Limited · 2011
- Oral composition containing dextranase and .alpha.-1,3 glucanase and a method for preventing and suppressing oral diseases using the same16US 4,438,093 AThe Research Foundation for Microbiai Diseases of Osaka University · 1984
- Mutanase14US 4,353,891 A1982